CN101282989A - 用于诊断风湿性疾病的方法 - Google Patents

用于诊断风湿性疾病的方法 Download PDF

Info

Publication number
CN101282989A
CN101282989A CNA2006800312026A CN200680031202A CN101282989A CN 101282989 A CN101282989 A CN 101282989A CN A2006800312026 A CNA2006800312026 A CN A2006800312026A CN 200680031202 A CN200680031202 A CN 200680031202A CN 101282989 A CN101282989 A CN 101282989A
Authority
CN
China
Prior art keywords
glu
leu
arg
ser
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800312026A
Other languages
English (en)
Chinese (zh)
Inventor
H·邦
W·贝格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orgentec Diagnostika GmbH
Original Assignee
Orgentec Diagnostika GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orgentec Diagnostika GmbH filed Critical Orgentec Diagnostika GmbH
Publication of CN101282989A publication Critical patent/CN101282989A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
CNA2006800312026A 2005-06-27 2006-06-27 用于诊断风湿性疾病的方法 Pending CN101282989A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005029845.1A DE102005029845B4 (de) 2005-06-27 2005-06-27 Verfahren zur Diagnose von rheumatischen Erkrankungen
DE102005029845.1 2005-06-27

Publications (1)

Publication Number Publication Date
CN101282989A true CN101282989A (zh) 2008-10-08

Family

ID=37309237

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800312026A Pending CN101282989A (zh) 2005-06-27 2006-06-27 用于诊断风湿性疾病的方法

Country Status (8)

Country Link
US (1) US8999921B2 (enExample)
EP (1) EP1896497B1 (enExample)
JP (2) JP5174659B2 (enExample)
CN (1) CN101282989A (enExample)
AU (1) AU2006263942B9 (enExample)
CA (1) CA2614103C (enExample)
DE (2) DE102005029845B4 (enExample)
WO (1) WO2007000320A2 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229652B (zh) * 2009-10-23 2012-05-23 山东省医药生物技术研究中心 抗类风湿性关节炎的多肽及其在制药中的应用
CN104823054A (zh) * 2012-08-07 2015-08-05 斯坎塞尔有限公司 对修饰后自体表位的抗肿瘤免疫应答
CN106950365A (zh) * 2017-02-15 2017-07-14 中国医学科学院北京协和医院 一种acpa阴性的ra诊断标志物及其应用
CN108026167A (zh) * 2015-06-10 2018-05-11 疫免医学有限公司 特异性结合分离的衍生自波形蛋白的肽的抗体或该肽的结合片段

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005029845B4 (de) 2005-06-27 2017-03-23 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von rheumatischen Erkrankungen
EP2171449A2 (en) * 2007-06-20 2010-04-07 Schering Corporation Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
EP2204380A1 (en) 2008-12-23 2010-07-07 Charité-Universitätsmedizin Berlin hnRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis
BRPI1013179A2 (pt) 2009-03-30 2019-09-24 Prometheus Laboratories Inc peptídeo sintético, métodos para detectar um anticorpo de proteína anti-citrulinado em uma amostra biológica, para realizar um ensaio para ajudar no diagnóstico ou prognóstico de artrite reumatóide, para melhorar a sensibilidade de diagnosticar ou prognosticar artrite reumatóide, ensaio para diagnosticar ou prognosticar artrite reumatóide, kit, e, método para identificar um peptídeo que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado
US10011883B2 (en) 2011-10-14 2018-07-03 New York University Causative agents and diagnostic methods relating to rheumatoid arthritis
WO2013151314A1 (ko) * 2012-04-03 2013-10-10 연세대학교 산학협력단 비멘틴을 포함하는 탈모 억제 또는 발모 촉진용 조성물
GB201512703D0 (en) 2015-07-20 2015-08-26 Scancell Ltd Anti-tumour immune responses to modified self-epitopes
GB201815041D0 (en) 2018-09-14 2018-10-31 Scancell Ltd Epitopes
WO2022108309A1 (ko) * 2020-11-18 2022-05-27 한양대학교 에리카산학협력단 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법
KR102511660B1 (ko) * 2020-11-18 2023-03-20 한양대학교 에리카산학협력단 비멘틴 돌연변이체 또는 이를 발현하는 벡터를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900473D0 (sv) * 1999-02-12 1999-02-12 Karolinska Innovations Ab Inhibitor of endothelial cell proliferation
JP2003501381A (ja) * 1999-06-07 2003-01-14 ユニバーシティ・オブ・シェフィールド 関節炎の処置
JP2007524583A (ja) * 2003-03-07 2007-08-30 ロンドン・ヘルス・サイエンシズ・センター・リサーチ・インコーポレーテッド 自己免疫異常に関わるｈｌａ−ｄｒｍｈｃクラスｉｉ分子に関するペプチド
DE102005029845B4 (de) 2005-06-27 2017-03-23 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von rheumatischen Erkrankungen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229652B (zh) * 2009-10-23 2012-05-23 山东省医药生物技术研究中心 抗类风湿性关节炎的多肽及其在制药中的应用
CN104823054A (zh) * 2012-08-07 2015-08-05 斯坎塞尔有限公司 对修饰后自体表位的抗肿瘤免疫应答
CN108026167A (zh) * 2015-06-10 2018-05-11 疫免医学有限公司 特异性结合分离的衍生自波形蛋白的肽的抗体或该肽的结合片段
CN114605529A (zh) * 2015-06-10 2022-06-10 疫免医学有限公司 特异性结合衍生自波形蛋白的肽的抗体或片段
CN106950365A (zh) * 2017-02-15 2017-07-14 中国医学科学院北京协和医院 一种acpa阴性的ra诊断标志物及其应用

Also Published As

Publication number Publication date
CA2614103C (en) 2015-02-24
US20090155822A1 (en) 2009-06-18
JP2008543961A (ja) 2008-12-04
AU2006263942B9 (en) 2012-08-02
EP1896497A2 (de) 2008-03-12
DE102005029845A1 (de) 2007-01-11
DE202006020682U1 (de) 2009-07-23
WO2007000320A3 (de) 2007-07-05
DE102005029845B4 (de) 2017-03-23
WO2007000320A2 (de) 2007-01-04
CA2614103A1 (en) 2007-01-04
JP5174659B2 (ja) 2013-04-03
US8999921B2 (en) 2015-04-07
AU2006263942A1 (en) 2007-01-04
EP1896497B1 (de) 2017-07-12
AU2006263942B2 (en) 2012-03-29
JP2013032358A (ja) 2013-02-14

Similar Documents

Publication Publication Date Title
JP2013032358A (ja) リウマチ疾患の診断方法
Monneaux et al. T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr mice
Peakman et al. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4
Monestier et al. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes
BR122013006960A2 (pt) Peptídeo sintético que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado, seu uso e seu método de identificação, bem como kit compreendendo o referido peptídeo
US20160153983A1 (en) Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
KR100328112B1 (ko) 류마토이드관절염병원관련관절염성펩티드에대항하는면역보호유도에유용한백신조성물과방법
US20180118801A1 (en) Compositions and methods for diagnosing and treating autoimmune diseases
Pourmand et al. Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus
CN101687908B (zh) 类风湿性关节炎特异性自身抗体的抗原决定簇及其用途
Clement et al. Autoimmune response to transthyretin in juvenile idiopathic arthritis
JPH09502346A (ja) 自己免疫疾患に関連するプロトコールにおけるミエリン希突起神経膠細胞糖蛋白質およびそのペプチド部分の使用
Billaut-Mulot et al. SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus
JPH11514852A (ja) 後天性副甲状腺機能低下症患者における自己抗体およびその測定方法
AU601963B2 (en) Modified beta-2-microglobulin
Igarashi et al. Stress-induced cell surface expression and antigenic alteration of the Ro/SSA autoantigen
CA2846479A1 (en) Method for measuring anti-wt1 antibody
CN101466732A (zh) Iv型胶原样免疫反应性多肽
JPH09218203A (ja) 杭原Ｓｍ−Ｄのペプチドおよびその利用、特にＳＬＥの診断法への利用
HK1124345A (en) Method for diagnosing rheumatic diseases
CA2374000A1 (en) Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
Briand et al. Generation of self-peptides to treat systemic lupus erythematosus
US20030013637A1 (en) Novel anti-autoimmune composition by inhibition of GRF action
JP5311117B2 (ja) 免疫細胞刺激活性を有する機能ペプチド
WO2008066483A1 (en) Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1124345

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20081008

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1124345

Country of ref document: HK